GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
Index / US Biomax / Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed / Product Detail : CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
#CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
Product name : Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
Catalog number : CR481
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed.
Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed storing antibdies for longer storage periods of the Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Cervical cancer tissue microarray, containing 12 cases of cervical squamous call carcinoma with 12 unmatched normal adjacent tissues, duplicated cores per case|
|Layout:||8 cols × 6 rows|
|Core Diameter:||1.5 mm|
|Quality Control:||Anti-Actin confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Cervical cancer tissue array with normal adjacent tissues, 24 cases_48 cores, with grade and stage data; ihc Anti-Actin confirmed
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1019: FAS pathway and Stress induction of HSP regulation
WP1062: Regulation of Actin Cytoskeleton
WP1138: FAS pathway and Stress induction of HSP regulation
WP1178: Regulation of Actin Cytoskeleton
WP1380: Regulation of Actin Cytoskeleton
WP1589: Folate-Alcohol and Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP1971: Integrated Cancer pathway
WP1984: Integrated Breast Cancer Pathway
WP2107: pathways in human cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2272: Pathogenic Escherichia coli infection
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2292: Chemokine signaling pathway
WP2335: sGC Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2367: Private Pancreatic Cancer
WP2377: Integrated Pancreatic Cancer Pathway
WP2378: pc12 data
WP2411: Cancer prevention Q
WP2429: Cancer prevention Q
WP314: FAS pathway and Stress induction of HSP regulation
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[DBNL CMAP SH3P7 PP5423] Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7)
[ZAK MLTK HCCS4] Mitogen-activated protein kinase kinase kinase MLT (EC 188.8.131.52) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
[HEXB HCC7] Beta-hexosaminidase subunit beta (EC 184.108.40.206) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]
[STMN2 SCG10 SCGN10] Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10)
[MUC5B MUC5] Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)
[Stmn2 Scg10 Scgn10] Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10)
[LETMD1] LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2)
[Stmn2 Scg10 Scgn10 Stmb2] Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10)
[FGFR3 JTK4] Fibroblast growth factor receptor 3 (FGFR-3) (EC 220.127.116.11) (CD antigen CD333)
[STK11 LKB1 PJS] Serine/threonine-protein kinase STK11 (EC 18.104.22.168) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19)
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 22.214.171.124) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[MRPS11 RPMS11 HCC2] 28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2)
[ATM] Serine-protein kinase ATM (EC 126.96.36.199) (Ataxia telangiectasia mutated) (A-T mutated)
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[GOLGA2] Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95)
[SIRT1 SIR2L1] NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[TTC23 HCC8] Tetratricopeptide repeat protein 23 (TPR repeat protein 23) (Cervical cancer proto-oncogene 8 protein) (HCC-8)
[TP63 KET P63 P73H P73L TP73L] Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 188.8.131.52) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[ITGB1 FNRB MDF2 MSK12] Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
[Letmd1 Mccr] LETM1 domain-containing protein 1 (Cervical cancer receptor) (MCC-32)
[PSEN1 AD3 PS1 PSNL1] Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)]
[STMN2 SCG10] Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10)
[BRI3BP KG19] BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1)
[TRIM27 RFP RNF76] Zinc finger protein RFP (EC 6.3.2.-) (RING finger protein 76) (Ret finger protein) (Tripartite motif-containing protein 27)
[EP300 P300] Histone acetyltransferase p300 (p300 HAT) (EC 184.108.40.206) (E1A-associated protein p300)
[ZSCAN32 ZNF434 HCCS5] Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434)
[SRC SRC1] Proto-oncogene tyrosine-protein kinase Src (EC 220.127.116.11) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)
 Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
 Venous air embolus during prone cervical spine fusion: case report.
 Changes in olfactory bulb volume following lateralized olfactory training.
 Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.
 Evaluation of the adequacy of requests for electrodiagnostic examination in a tertiary referral center.
 5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.
 Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.
 Effectiveness of four outreach modalities to patients overdue for cervical cancer screening in the primary care setting: a randomized trial.
 Seven protective miRNA signatures for prognosis of cervical cancer.
 Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model.
Enter catalog number :